Important Message for Recent Recipients of the Johnson & Johnson (J&J) COVID-19 Vaccine

IMPORTANT NOTICE: As you may know, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (U.S. Food and Drug Administration) have paused the administration of the Johnson & Johnson (J & J) vaccine to review data involving six cases of a rare and severe type of blood clot in women who were between the ages of 18 and 48.

This pause does not affect the Pfizer and Moderna vaccines.

The first thing to understand is that this adverse event is very rare – more than 6.8 million doses of the J & J vaccine have been administered in the U.S. and there have only been six cases of this blood clotting. None of these blood clot cases have been in New Jersey.

The blood clot, in the six cases, is called a cerebral venous sinus thrombosis (CVST) in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred within 6 to 13 days after vaccination.

If you have received the J&J vaccine, you should not be overly concerned. You should, however, contact your physician or health care provider if you experience any of the following symptoms within three weeks after you have received the J & J vaccine: severe headache, abdominal pain, leg pain, or shortness of breath. If you do not have a primary care physician, you can click here to find a Cooper University Health Care primary care physician.

For additional information and any updates, you can visit the CDC’s website vaccine page.

Leave a Reply

DO NOT USE THIS FORM FOR APPOINTMENTS. Using this form will only delay your ability to get an appointment. Please use the contact information in the article or visit